measured by neutrophil, procalcitonin serum, , leucocyte, CRP, and length of clinical improvement.
1.09 and treatment group −1.07 AE 0.81 mg/L (P = 0.28). We found clinical improvement in control group 6.00 AE 1,826 and treatment group 5.36 AE 1,082 (P = 0,488). Background and Aims: Nontuberculous mycobacterium (NTM), especially mycobacterium-avium complex (MAC) is increasing in the world. The principal criteria to diagnose NTM require multiple isolation of same NTM species from biological samples, absence of Mycobacterium tuberculosis and presence of clinical manifestation. Recently, an enzyme immunoassay (EIA) that detects serum immunoglobulin A antibody reacting to the glycopeptidolipid core antigen of MAC was developed, this EIA kit is using for rapid diagnosis of MAC and for differentiating MAC from pulmonary tuberculosis. The aim of this study is to clarify whether the antibody can be a supplementary diagnosis of MAC severity comparing with the clinical features and chest computed tomography (CT).
Conclusion

Methods:
We investigated the 82 patients (74.4% ware female, the mean age was 71. AE 0.0) with MAC met current the ATS/IDSA microbiological criteria between May 2015 and May 2018. All patients were evaluated the characteristics, chest CT findings and mycobacterium-avium complex antibody. Image findings were classified as nodules, consolidation, cavity and bronchiectasis, and we have compared with the antibody level and image features in each group.
Results: There were 29.3% of the cases below the cut off value (0.7U/mL). In the group of low mycobacterium-avium complex antibody, there were significantly observed the cases with immunosuppressed underlying disease (45.8% vs 32.8%, P<0.05). In the group of high mycobacterium-avium complex antibody, the prevalence of female was higher (77.6% vs 66.7%), and the age was younger (70.2 vs 73.1 years). In image findings, bronchiectasis was significantly observed.
Conclusion:
It was considered that we should be careful, because there were the cases in which the value of mycobacterium-avium complex antibody measured low. Background and Aims: The incidence of non-tuberculous mycobacterial (NTM) disease is reportedly increasing globally. In Japan, the incidence rate was 14.7/100,000 person-years in 2014, and 2.6 times higher than in 2007. The antibiotic treatment is prolonged, usually 1-2 years, because of the modest long term response rate. Some patients remain asymptomatic, but most patients progress over time gradually, and deciding to treat or observe is sometimes difficult. The immune response against NTM infection is not fully understood. Therefore, we assessed the cytokine response in NTM patients related to mycobacterial antigens stimulated peripheral blood mononuclear cells (PBMCs).
Methods: Outpatients (defined or suspected of NTM) were recruited at the Nagasaki University hospital. We isolated PBMCs and stimulated them with mycobacterial antigens. After overnight incubation, we did surface and intracellular cytokine staining, Cytokine responses (IL-2, IL-10, IL-13, IL-17A, TNF-α, IFN-γ) were analyzed with multicolour flow cytometry.
Results:
We recruited 15 patients (3 males and 12 females). The mean age was 65 years old. They were all non-HIV patients. 4 patients had immunosuppressive drugs. 2 patients had latent tuberculosis infection. The pathogens were 8 Mycobacterium intracellular, 6 M. avium, 1 M. abscessus, and 1 unknown. 7 patients were under treatment, 5 were after treatment, and 3 were non-treated. The disease status was stable except for one patient. In this patient stimulated with PPD, IFN-γ response was more elevated than other patients (IFN-γ producing CD4+ T cells/All CD4+ T cells ; 0.27% vs 0.053%). TNF-α responses were elevated in all 15 patients stimulated with PPD. TNF-α responses were also elevated in 11 patients stimulated with ESAT-6/CFP-10.
Conclusion:
The cytokine responses may vary according to the status in NTM infection. Vigorous IFN-γ response to PPD in NTM patients may distinguish active stage from chronic one. The second hospital of JiLin University, China Background and Aims: In recent years, the incidence rate of pulmonary cryptococcosis (PC) is increasing. Its clinical and imaging features are lack of specificity and the invasive biopsy is hard to be accepted, so the pathogenic detection rate is low and difficult to diagnosis this disease. Therefore, the use of cryptococcal antigen as an auxiliary immunological examination method is necessary. To study the sensitivity and specificity of colloidal gold method in the diagnosis of PC, in order to evaluate the clinical significance of the diagnosis of pulmonary cryptococcosis in the absence of pathological support.
Methods: Collect information of all patients who were suspected PC and examined by colloidal gold method. Calculate the sensitivity and specificity of colloidal gold method.
Results: There were 19 cases positive and 112 negative among the 131 cases of colloidal gold. In the positive cases, 13 patients were clinical diagnose of PC and others were not PC. The 112 negative cases were non PC patients. The sensitivity of colloidal gold method was 100% and the specificity was 94.92%. The positive predictive value was 68.42% and the negative predictive value was 100%.
In this study, the sensitivity of colloidal gold method was 100% and the specificity was 94.92%. The colloidal gold method has high value in the diagnosis and differential diagnosis of pulmonary cryptococcosis. And this method is stable at room temperature and its operation is simple, which needs 10 minutes to take the result. The positive predictive value was 68.42% and the negative predictive value was 100%. Therefore it can be used as an exclusive method for cryptococcal infection.
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